BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21962092)

  • 1. Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: a randomized, double-blind, placebo-controlled trial.
    Bensch GW; Greos LS; Gawchik S; Kpamegan E; Newman KB
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):323-9. PubMed ID: 21962092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009471. PubMed ID: 25030198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
    Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma.
    Gillman SA; Anolik R; Schenkel E; Newman K
    Clin Pediatr (Phila); 2002 Jun; 41(5):333-40. PubMed ID: 12086199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flunisolide HFA.
    Waugh J; Goa KL
    Am J Respir Med; 2002; 1(5):369-72; discussion 373. PubMed ID: 14720039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
    Corren J; Tashkin DP
    Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department.
    Brenner BE; Chavda KK; Camargo CA
    Ann Emerg Med; 2000 Nov; 36(5):417-26. PubMed ID: 11054193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flunisolide for the treatment of asthma.
    Melani AS
    Expert Rev Clin Pharmacol; 2014 May; 7(3):251-8. PubMed ID: 24716719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
    Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
    Scott MB; Skoner DP
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
    Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
    Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children.
    Nakanishi AK; Klasner AK; Rubin BK
    Chest; 2003 Sep; 124(3):790-4. PubMed ID: 12969999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis.
    Sharek PJ; Bergman DA
    Pediatrics; 2000 Jul; 106(1):E8. PubMed ID: 10878177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flunisolide HFA for the treatment of asthma: an old friend reformulated.
    Shafazand S; Colice G
    Expert Opin Pharmacother; 2004 May; 5(5):1163-73. PubMed ID: 15155115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.
    Skoner DP; Szefler SJ; Welch M; Walton-Bowen K; Cruz-Rivera M; Smith JA
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):259-68. PubMed ID: 10669845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma.
    Allen ED; Whitaker ER; Ryu G
    Pediatr Pulmonol; 1997 Dec; 24(6):397-405. PubMed ID: 9448231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: an updated review.
    Berger WE; Tashkin DP
    Allergy Asthma Proc; 2015; 36(2):105-15. PubMed ID: 25635610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma.
    Skoner DP; Maspero J; Banerji D;
    Pediatrics; 2008 Jan; 121(1):e1-14. PubMed ID: 18070931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.